当前位置：首页 SCI 期刊医学 Clinical & Translational Oncology(非官网)

Clinical & Translational OncologySCIE

国际简称：CLIN TRANSL ONCOL 参考译名：临床和转化肿瘤学

中科院分区
3区
CiteScore分区
Q2
JCR分区
Q2

基本信息：: ISSN：1699-048X; E-ISSN：1699-3055; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：SPAIN; 出版商：Springer International Publishing; 出版语言：English; 出版周期：Monthly; 出版年份：2000; 研究方向：肿瘤学-医学

评价信息：: 影响因子：2.8; H-index：42; CiteScore指数：6.2; SJR指数：0.837; SNIP指数：0.79

发文数据：: Gold OA文章占比：21.58%; 研究类文章占比：75.61%; 年发文量：287; 自引率：0.0294...; 开源占比：0.1792; 出版撤稿占比：0; 出版国人文章占比：0.25; OA被引用占比：0.2184...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Clinical & Translational Oncology期刊介绍

Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.

期刊简介Clinical & Translational Oncology期刊介绍

《Clinical & Translational Oncology》自2000出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：约2.2月
医学
ONCOLOGY
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Clinical & Translational Oncology Cite Score数据

CiteScore：6.2
SJR：0.837
SNIP：0.79

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q2	121 / 404	70%
大类：Medicine 小类：Cancer Research	Q2	101 / 230	56%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Clinical & Translational Oncology 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	ONCOLOGY 肿瘤学	4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Clinical & Translational Oncology JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	157 / 322	51.4%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q3	177 / 322	45.19%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
Spain351
CHINA MAINLAND234
USA62
Italy39
Iran27
England17
France17
Egypt13
Canada12
Turkey12

本刊中国学者近年发表论文

1、Tumor mutational burden and efficacy of chemotherapy in lung cancer
Author: Song, Juan; Yan, Yu; Chen, Cuicui; Li, Jiamin; Ding, Ning; Xu, Nuo; Bao, Hairong; Zhang, Xin; Hong, Qunying; Zhou, Jian; Shao, Yang W.; Song, Yuanlin; Tong, Lin; Hu, Jie

Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; Vol. 25, Issue 1, pp. 173-184. DOI: 10.1007/s12094-022-02924-6
2、The correlations between psychological distress, cognitive impairment and quality of life in patients with brain metastases after whole-brain radiotherapy
Author: Yao, Senbang; Zuo, He; Li, Wen; Cai, Yinlian; Zhang, Qianqian; Pang, Lulian; Jing, Yanyan; Yin, Xiangxiang; Cheng, Huaidong

Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; Vol. 25, Issue 1, pp. 207-217. DOI: 10.1007/s12094-022-02927-3
3、A research review of experimental animal models with myelodysplastic syndrome
Author: Chen, Gen-Wang; Chen, Mei-Na; Liu, Lei; Zheng, Yu-Yu; Wang, Jin-Peng; Gong, Si-Si; Huang, Rong-Fu; Fan, Chun-Mei; Chen, Yue-Zu

Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; Vol. 25, Issue 1, pp. 105-113. DOI: 10.1007/s12094-022-02931-7
4、The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis
Author: Zhang, Xingxing; Bai, Wenxiu; Hu, Lisha; Ha, Hualan; Du, Yuelin; Xiong, Wei; Wang, Hongbo; Shang, Panfeng

Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; Vol. 25, Issue 1, pp. 91-104. DOI: 10.1007/s12094-022-02932-6
5、Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy
Author: Chen, Dujuan; Qin, Hongyue; Deng, Guangchuan; Wang, Qi; Wang, Haiyong; Liu, Xijun

Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; Vol. 25, Issue 1, pp. 226-235. DOI: 10.1007/s12094-022-02936-2
6、DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer
Author: Li, Yuan; Liao, Leen; Kong, Lingheng; Jiang, Wu; Tang, Jinghua; Han, Kai; Hou, Zhenlin; Zhang, Chenzhi; Zhou, Chi; Zhang, Linjie; Sui, Qiaoqi; Xiao, Binyi; Mei, Weijian; Xu, Yanbo; Yu, Jiehai; Hong, Zhigang; Pan, Zhizhong; Ding, Peirong

Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; Vol. 25, Issue 1, pp. 218-225. DOI: 10.1007/s12094-022-02930-8
7、The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease
Author: Lu, Juan; Zhu, Danhua; Zhang, Xiaoqian; Wang, Jie; Cao, Hongcui; Li, Lanjuan

Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; Vol. 25, Issue 1, pp. 137-150. DOI: 10.1007/s12094-022-02943-3
8、Targeted delivery of nuclear targeting probe for bladder cancer using cyclic pentapeptide c(RGDfK) and acridine orange
Author: Qin, Jiaxin; Liang, Qing; Wang, Guangyue; Hao, Lin; Liu, Xing; Wang, Xinlei; Hu, Zhengxiang; Fang, Gaochuan; Xue, Liang; Zhao, Yan; Li, Rui; Lv, Qian; Wen, Jiling; Yang, Guosheng; Han, Conghui; Shi, Zhenduo

Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; Vol. 25, Issue 2, pp. 375-383. DOI: 10.1007/s12094-022-02938-0